Department of Plastic and Reconstructive Surgery, Keio University School of Medicine, Shinjuku, Tokyo, Japan.
Aging (Albany NY). 2022 Sep 7;14(20):8167-8178. doi: 10.18632/aging.204273.
There is growing evidence that the appearance and texture of the skin that is altered during the aging process are considerably enhanced by the accumulation of senescent dermal fibroblasts. These senescent cells magnify aging via an inflammatory, histolytic, and senescence-associated secretory phenotype (SASP). Secreted frizzled-related protein 4 (SFRP4) was previously determined to be expressed in dermal fibroblasts of aging skin, and its increased expression has been shown to promote cellular senescence. However, its role in the SASP remains unknown. We found that SFRP4 was significantly expressed in p16ink4a-positive human skin fibroblasts and that treatment with recombinant SFRP4 promoted SASP and senescence, whereas siRNA knockdown of SFRP4 suppressed SASP. Furthermore, we found that knockdown of SFRP4 in mouse skin ameliorates age-related reduction of subcutaneous adipose tissue, panniculus carnosus muscle layer, and thinning and dispersion of collagen fibers. These findings suggest a potential candidate for the development of new skin rejuvenation therapies that suppress SASP.
越来越多的证据表明,在衰老过程中皮肤的外观和质地的改变,很大程度上是由于衰老的真皮成纤维细胞的积累。这些衰老细胞通过炎症、组织溶解和衰老相关的分泌表型(SASP)放大衰老。先前已经确定分泌卷曲相关蛋白 4(SFRP4)在衰老皮肤的真皮成纤维细胞中表达,并且其表达增加已被证明可促进细胞衰老。然而,其在 SASP 中的作用尚不清楚。我们发现 SFRP4 在 p16ink4a 阳性的人皮肤成纤维细胞中显著表达,并且用重组 SFRP4 处理可促进 SASP 和衰老,而 SFRP4 的 siRNA 敲低则抑制 SASP。此外,我们发现 SFRP4 在小鼠皮肤中的敲低可改善与年龄相关的皮下脂肪组织、背阔肌肌层以及胶原蛋白纤维变薄和分散的减少。这些发现表明,抑制 SASP 的新型皮肤年轻化疗法的开发具有潜在的候选药物。